Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Pharmacielo Ltd V.PCLO

Alternate Symbol(s):  PCLOF

PharmaCielo Ltd. is a Canada-based company with a focus on ethical and sustainable processing and supplying of all natural, pharmaceutical-grade medical cannabis products to channel distributors. The Company has two subsidiaries, PharmaCielo Colombia Holdings S.A.S. (PharmaCielo Colombia) and Ubiquo Telemedicina S.A.S. (Ubiquo). PharmaCielo Colombia cultivates and processes the Company’s all-natural cannabis into standardized, medicinal-grade oil extracts and related products. In Colombia, PharmaCielo Colombia is a licensed cultivator, producer, and distributor of both TetraHydroCannabinol (THC) and Cannabidiol (CBD) medical cannabis for use in Colombia, international export, and research purposes. Ubiquo is a knowledge management and medical consultation system that focuses on creating access to healthcare for Colombians. Ubiquo is a technology platform and a user interface that allows doctors and patients to communicate. Ubiquo is used as a communication tool.


TSXV:PCLO - Post by User

Bullboard Posts
Comment by Dmajormineron Oct 02, 2019 6:22am
132 Views
Post# 30185642

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Misleading news release

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Misleading news releaseRandomtask.  So funny.  The Grit Capital arranged dog and pony show.  I'm on it.  Several foxes in the hen house on this trip. Companies should do a better job screening.  Didn't bother with the PCLO show as a freind took care of that and saw or heard nothing to remotely justify the valuation vs lots of U.S companies with decent cash positions that will have $200- $500 MM in sales in 2020 and are trading at massively better valuations than crappy PCLO.  The market these days is all about cash remaining as there are no sources of funding that are not hugely egregious.  Only the very best companies with lots of cash will survive and PCLO is not one of them. 

If you want a tip then the best company out there valuation wise and with $80 MM cash plus a nice stake in Origin House / Cresco Lans is a company called Jushi.  Its trading at a valuation of nearly 70% cash and   .6 x next years sales.  Why would anyone want to own a massively overvalued company that is years away from any revenues such as PCLO when there are gems like this available.   Cresco Labs, GTII, Cura, Cronos , are also cashed up and very cheap.  The current perception out there is to short overvalued companies short on cash and with no forseeable meaninful revenues such as PCLO and pair it up with longs such as Jushi or Creco Labs, etc. 

Later.....got to head to the airport in a few hours to come home.
Bullboard Posts